{"title":"New product intros [almonertinib, bempedoic acid (first-in-class), cetirizine hydrochloride (new formulation), calaspargase pegol-mknl, eptinezumab-jjmr, lumateperone tosylate, luspatercept (new indication), remimazolam tosylate, teprotumumab-trbw]","authors":"S. Babu","doi":"10.1358/dot.2020.56.5.3160353","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"56 1","pages":"349"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicamentos de actualidad. Drugs of today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1358/dot.2020.56.5.3160353","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
新产品引进[阿莫那替尼、苯甲多酸(同类首创)、盐酸西替利嗪(新配方)、calaspargase pegolmknl、eptinzumab -jjmr、lumateperone tosyate、luspatercept(新适应症)、remimazolam tosyate、teprotumumab-trbw]
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
